CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company
SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoB...
2020-08-13 10:00
10878